Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus
- PMID: 10802654
- DOI: 10.1038/75578
Mutations in TFAP2B cause Char syndrome, a familial form of patent ductus arteriosus
Abstract
Char syndrome is an autosomal dominant trait characterized by patent ductus arteriosus, facial dysmorphism and hand anomalies. Using a positional candidacy strategy, we mapped TFAP2B, encoding a transcription factor expressed in neural crest cells, to the Char syndrome critical region and identified missense mutations altering conserved residues in two affected families. Mutant TFAP2B proteins dimerized properly in vitro, but showed abnormal binding to TFAP2 target sequence. Dimerization of both mutants with normal TFAP2B adversely affected transactivation, demonstrating a dominant-negative mechanism. Our work shows that TFAP2B has a role in ductal, facial and limb development and suggests that Char syndrome results from derangement of neural-crest-cell derivatives.
Similar articles
-
Syndromic patent ductus arteriosus: evidence for haploinsufficient TFAP2B mutations and identification of a linked sleep disorder.Proc Natl Acad Sci U S A. 2005 Feb 22;102(8):2975-9. doi: 10.1073/pnas.0409852102. Epub 2005 Jan 31. Proc Natl Acad Sci U S A. 2005. PMID: 15684060 Free PMC article.
-
Novel TFAP2B mutations that cause Char syndrome provide a genotype-phenotype correlation.Am J Hum Genet. 2001 Oct;69(4):695-703. doi: 10.1086/323410. Epub 2001 Aug 14. Am J Hum Genet. 2001. PMID: 11505339 Free PMC article.
-
Char Syndrome a novel mutation and new insights: A clinical report.Eur J Med Genet. 2019 Dec;62(12):103607. doi: 10.1016/j.ejmg.2018.12.012. Epub 2018 Dec 21. Eur J Med Genet. 2019. PMID: 30579973
-
[Research progress of genetic research on Char syndrome].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2024 Jun 10;41(6):758-760. doi: 10.3760/cma.j.cn511374-20210607-00478. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2024. PMID: 38818565 Review. Chinese.
-
Molecular determinants of atrial and ventricular septal defects and patent ductus arteriosus.Am J Med Genet. 2000 Winter;97(4):304-9. doi: 10.1002/1096-8628(200024)97:4<304::aid-ajmg1281>3.0.co;2-#. Am J Med Genet. 2000. PMID: 11376442 Review.
Cited by
-
CHD7 promotes neural progenitor differentiation in embryonic stem cells via altered chromatin accessibility and nascent gene expression.Sci Rep. 2020 Oct 15;10(1):17445. doi: 10.1038/s41598-020-74537-4. Sci Rep. 2020. PMID: 33060836 Free PMC article.
-
A subpopulation of smooth muscle cells, derived from melanocyte-competent precursors, prevents patent ductus arteriosus.PLoS One. 2013;8(1):e53183. doi: 10.1371/journal.pone.0053183. Epub 2013 Jan 31. PLoS One. 2013. PMID: 23382837 Free PMC article.
-
Heterodimerization of TFAP2 pioneer factors drives epigenomic remodeling during neural crest specification.Genome Res. 2020 Jan;30(1):35-48. doi: 10.1101/gr.249680.119. Epub 2019 Dec 17. Genome Res. 2020. PMID: 31848212 Free PMC article.
-
The genetics of congenital heart disease.J Nucl Cardiol. 2003 Jan-Feb;10(1):71-6. doi: 10.1067/mnc.2003.129294. J Nucl Cardiol. 2003. PMID: 12569334 Review. No abstract available.
-
Rare Variants in Novel Candidate Genes Associated With Nonsyndromic Patent Ductus Arteriosus Identified With Whole-Exome Sequencing.Front Genet. 2022 Jun 6;13:921925. doi: 10.3389/fgene.2022.921925. eCollection 2022. Front Genet. 2022. PMID: 35734438 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases